CD34+ Humanized huHSC-NCG Mice Engrafted with Hematological Malignancies Models for Preclinical Study of Anti-Human CD19 Therapeutic Antibodies

March 30, 2022

1670933302934053299_1.png

Next : CD137 Humanized Mice for Preclinical Efficacy Evaluation of anti-CD137 Therapeutic Antibodies Previous：A Humanized PD-1/LAG-3 Dual Immune Checkpoint Knock-in Mouse Model for Preclinical Evaluation of Combination Anti-PD-1/LAG-3 Therapy